249 related articles for article (PubMed ID: 22042972)
21. Overexpression of SIP1 and downregulation of E-cadherin predict delayed neck metastasis in stage I/II oral tongue squamous cell carcinoma after partial glossectomy.
Sakamoto K; Imanishi Y; Tomita T; Shimoda M; Kameyama K; Shibata K; Sakai N; Ozawa H; Shigetomi S; Fujii R; Fujii M; Ogawa K
Ann Surg Oncol; 2012 Feb; 19(2):612-9. PubMed ID: 21913013
[TBL] [Abstract][Full Text] [Related]
22. Overexpression of RhoGDI2 correlates with tumor progression and poor prognosis in colorectal carcinoma.
Li X; Wang J; Zhang X; Zeng Y; Liang L; Ding Y
Ann Surg Oncol; 2012 Jan; 19(1):145-53. PubMed ID: 21861235
[TBL] [Abstract][Full Text] [Related]
23. 14-3-3sigma expression is an independent prognostic parameter for poor survival in colorectal carcinoma patients.
Perathoner A; Pirkebner D; Brandacher G; Spizzo G; Stadlmann S; Obrist P; Margreiter R; Amberger A
Clin Cancer Res; 2005 May; 11(9):3274-9. PubMed ID: 15867223
[TBL] [Abstract][Full Text] [Related]
24. ZEB2 promotes the metastasis of gastric cancer and modulates epithelial mesenchymal transition of gastric cancer cells.
Dai YH; Tang YP; Zhu HY; Lv L; Chu Y; Zhou YQ; Huo JR
Dig Dis Sci; 2012 May; 57(5):1253-60. PubMed ID: 22350782
[TBL] [Abstract][Full Text] [Related]
25. Clinical significance of osteoprotegerin expression in human colorectal cancer.
Tsukamoto S; Ishikawa T; Iida S; Ishiguro M; Mogushi K; Mizushima H; Uetake H; Tanaka H; Sugihara K
Clin Cancer Res; 2011 Apr; 17(8):2444-50. PubMed ID: 21270110
[TBL] [Abstract][Full Text] [Related]
26. SIX1 promotes epithelial-mesenchymal transition in colorectal cancer through ZEB1 activation.
Ono H; Imoto I; Kozaki K; Tsuda H; Matsui T; Kurasawa Y; Muramatsu T; Sugihara K; Inazawa J
Oncogene; 2012 Nov; 31(47):4923-34. PubMed ID: 22286765
[TBL] [Abstract][Full Text] [Related]
27. Expression of KITENIN in human colorectal cancer and its relation to tumor behavior and progression.
Lee S; Song YA; Park YL; Cho SB; Lee WS; Lee JH; Chung IJ; Kim KK; Rew JS; Joo YE
Pathol Int; 2011 Apr; 61(4):210-20. PubMed ID: 21418393
[TBL] [Abstract][Full Text] [Related]
28. Clinical significance of human kallikrein 10 gene expression in colorectal cancer and gastric cancer.
Feng B; Xu WB; Zheng MH; Ma JJ; Cai Q; Zhang Y; Ji J; Lu AG; Qu Y; Li JW; Wang ML; Hu WG; Liu BY; Zhu ZG
J Gastroenterol Hepatol; 2006 Oct; 21(10):1596-603. PubMed ID: 16928223
[TBL] [Abstract][Full Text] [Related]
29. Clinical significance of TROP2 expression in colorectal cancer.
Ohmachi T; Tanaka F; Mimori K; Inoue H; Yanaga K; Mori M
Clin Cancer Res; 2006 May; 12(10):3057-63. PubMed ID: 16707602
[TBL] [Abstract][Full Text] [Related]
30. Up-regulation of the hypoxia-inducible factor-1 transcriptional pathway in colorectal carcinomas.
Furlan D; Sahnane N; Carnevali I; Cerutti R; Bertoni F; Kwee I; Uccella S; Bertolini V; Chiaravalli AM; Capella C
Hum Pathol; 2008 Oct; 39(10):1483-94. PubMed ID: 18619649
[TBL] [Abstract][Full Text] [Related]
31. Epithelial-mesenchymal transition (EMT) protein expression in a cohort of stage II colorectal cancer patients with characterized tumor budding and mismatch repair protein status.
Kevans D; Wang LM; Sheahan K; Hyland J; O'Donoghue D; Mulcahy H; O'Sullivan J
Int J Surg Pathol; 2011 Dec; 19(6):751-60. PubMed ID: 21791486
[TBL] [Abstract][Full Text] [Related]
32. Downregulation of Mus81 as a novel prognostic biomarker for patients with colorectal carcinoma.
Wu F; Shirahata A; Sakuraba K; Kitamura Y; Goto T; Saito M; Ishibashi K; Kigawa G; Nemoto H; Sanada Y; Hibi K
Cancer Sci; 2011 Feb; 102(2):472-7. PubMed ID: 21175991
[TBL] [Abstract][Full Text] [Related]
33. Clinicopathological significance of the gene expression of matrix metalloproteinase-7, insulin-like growth factor-1, insulin-like growth factor-2 and insulin-like growth factor-1 receptor in patients with colorectal cancer: insulin-like growth factor-1 receptor gene expression is a useful predictor of liver metastasis from colorectal cancer.
Oshima T; Akaike M; Yoshihara K; Shiozawa M; Yamamoto N; Sato T; Yamada R; Fujii S; Rino Y; Kunisaki C; Tanaka K; Masuda M; Imada T
Oncol Rep; 2008 Aug; 20(2):359-64. PubMed ID: 18636198
[TBL] [Abstract][Full Text] [Related]
34. Parafibromin expression is an independent prognostic factor for colorectal carcinomas.
Zheng HC; Wei ZL; Xu XY; Nie XC; Yang X; Takahashi H; Takano Y
Hum Pathol; 2011 Aug; 42(8):1089-102. PubMed ID: 21315421
[TBL] [Abstract][Full Text] [Related]
35. Prognostic significance of TWEAK expression in colorectal cancer and effect of its inhibition on invasion.
Lin BR; Huang MT; Chen ST; Jeng YM; Li YJ; Liang JT; Lee PH; Chang KJ; Chang CC
Ann Surg Oncol; 2012 Jul; 19 Suppl 3():S385-94. PubMed ID: 21681381
[TBL] [Abstract][Full Text] [Related]
36. Regulation of ovarian cancer progression by microRNA-187 through targeting Disabled homolog-2.
Chao A; Lin CY; Lee YS; Tsai CL; Wei PC; Hsueh S; Wu TI; Tsai CN; Wang CJ; Chao AS; Wang TH; Lai CH
Oncogene; 2012 Feb; 31(6):764-75. PubMed ID: 21725366
[TBL] [Abstract][Full Text] [Related]
37. Overexpression of IQGAP1 in advanced colorectal cancer correlates with poor prognosis-critical role in tumor invasion.
Hayashi H; Nabeshima K; Aoki M; Hamasaki M; Enatsu S; Yamauchi Y; Yamashita Y; Iwasaki H
Int J Cancer; 2010 Jun; 126(11):2563-74. PubMed ID: 19856315
[TBL] [Abstract][Full Text] [Related]
38. Overexpression of the fibroblast growth factor receptor-1 gene correlates with liver metastasis in colorectal cancer.
Sato T; Oshima T; Yoshihara K; Yamamoto N; Yamada R; Nagano Y; Fujii S; Kunisaki C; Shiozawa M; Akaike M; Rino Y; Tanaka K; Masuda M; Imada T
Oncol Rep; 2009 Jan; 21(1):211-6. PubMed ID: 19082464
[TBL] [Abstract][Full Text] [Related]
39. Functional role and prognostic significance of CD157 in ovarian carcinoma.
Ortolan E; Arisio R; Morone S; Bovino P; Lo-Buono N; Nacci G; Parrotta R; Katsaros D; Rapa I; Migliaretti G; Ferrero E; Volante M; Funaro A
J Natl Cancer Inst; 2010 Aug; 102(15):1160-77. PubMed ID: 20639476
[TBL] [Abstract][Full Text] [Related]
40. The expression pattern of aldehyde dehydrogenase 1 (ALDH1) is an independent prognostic marker for low survival in colorectal tumors.
Vogler T; Kriegl L; Horst D; Engel J; Sagebiel S; Schäffauer AJ; Kirchner T; Jung A
Exp Mol Pathol; 2012 Feb; 92(1):111-7. PubMed ID: 22101256
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
